Zapped saline could zap bladder tumors
NCT ID NCT07272603
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new treatment called Plasma-Activated Saline Solution (PASS) for bladder cancer. Five patients will receive a one-week course of PASS infused directly into the bladder before their scheduled surgery. Researchers will check if the treatment shrinks tumors and kills cancer cells, while closely watching for side effects. The goal is to see if this approach is safe and worth studying further.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Plasma-Activated Saline Solution (PASS)
- What this could lead to
- If it works, this could point toward a new, non-toxic way to shrink bladder tumors before surgery.
- What could go wrong
- This is a very early, tiny trial with only 5 people. It's designed mainly to check safety, not to prove it works. The treatment may not shrink tumors or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER (UROTHELIAL, TRANSITIONAL CELL) CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bladder-Instilled biologic keep recurrent bladder cancer at bay?
- Could a common vitamin restore immunotherapy power after antibiotics?
- Could less be more? bladder cancer trial tests stopping immunotherapy after tumors vanish
- Could bladder bacteria trigger cancer? new study investigates
- Bladder cancer surgery: new clues in fluid and DNA may predict recurrence
- New test could spot tumours that dodge radiotherapy